Research and analysis

Genetically Modified Organisms: Sanofi Pasteur, Inc. (24/R56/01)

Details of the consent for Sanofi Pasteur, Inc. to release a genetically modified organism, reference 24/R56/01.

Documents

Consent letter (reference 24/R56/01)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Variation to consent letter (reference 24/R56/01)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Parts A1 to A6: Application for consent to release a GMO – organisms other than higher plants

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Part B: Information about the release application to be included on the public register

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Consent documents for Sanofi Pasteur, Inc. to release a genetically modified organism, reference 24/R56/01.

Each consent granted includes:

  • consent letter (confirming consent and outlining any conditions)
  • part A1-A6: Information required under schedule 1 of the Genetically Modified Organisms (Deliberate Release) regulations 2002
  • part B: Information about the release application to be included on the public register

ACRE advice

ACRE advice: application for a vaccine trial of genetically modified Respiratory Syncytial Virus (24/R56/01)

Updates to this page

Published 11 January 2024
Last updated 22 October 2024 + show all updates
  1. Added variation to consent letter (reference 24/R56/01).

  2. We have updated this application as consent has been granted. We have also added a link to the ACRE advice about the application.

  3. First published.

Sign up for emails or print this page